Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

T8703

Sigma-Aldrich

T0070907

≥98% (HPLC)

Synonym(s):

2-Chloro-5-nitro-N-4-pyridinyl-benzamide, Benzamide, 2-chloro-5-nitro-N-4-pyridinyl-

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
$188.00
25 MG
$503.30

$188.00

Available to ship onMay 02, 2025Details

Request a Bulk Order
Notify Me

Get notified when this item is ready to ship via email.

All Photos(1)

Select a Size

Change View
5 MG
$188.00
25 MG
$503.30

About This Item

Empirical Formula (Hill Notation):
C12H8ClN3O3
CAS Number:
313516-66-4
Molecular Weight:
277.66
MDL number:
MFCD00121849
UNSPSC Code:
12352203
PubChem Substance ID:
329826884
NACRES:
NA.77

$188.00

Available to ship onMay 02, 2025Details

Request a Bulk Order
Notify Me

Get notified when this item is ready to ship via email.

Quality Level

100

assay

≥98% (HPLC)

form

powder

color

white

solubility

DMSO: >10 mg/mL
H2O: insoluble

storage temp.

2-8°C

SMILES string

[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccncc2

InChI

1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17)

InChI key

FRPJSHKMZHWJBE-UHFFFAOYSA-N

Related Categories

General description

T0070907 has antimicrotubule,[1] antitumor and radiosensitizing properties. It decreases tubulin protein levels, which is associated with cell cycle arrest, apoptosis and also reduces metastasis of colorectal carcinoma cells.[2] T0070907 is used as a therapeutic target in breast cancer.[3] It stimulates proteasome-dependent degradation of tubulin.[4]

Application

T0070907 has been used to reduce peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in lipopolysaccharide (LPS)-induced leukemia RAW264.7 cell line.[5] It also has been used to evaluate the involvement of wogonin in alleviating EtOH (ethanol)-induced inflammation in RAW264.7 cell line.[6]
T0070907 or Benzamide has been used as a ADP-ribosyltransferase (ADPRT) inhibitor in rat hippocampal slices[7]. It has also been used for urine analysis in patients diagnosed with acute uncomplicated urinary tract infection[8].

Biochem/physiol Actions

T0070907 is a PPAR-γ antagonist.
T0070907 is very similar in structure and activity to the PPAR-γ antagonist GW9662. T0070907 is more potent and has higher selectivity for PPAR-γ over all other subtypes (about 800-fold) whereas GW9662 has been reported to have some PPAR-α agonist activity.

Features and Benefits

This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Preparation Note

T0070907 is soluble in DMSO at a concentration that is greater than 10 mg/ml.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 2

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000221873
0000221874
0000162990
0000162989
046M4621V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51
An Z, et al.
Toxicology in vitro, 37, 1-8 (2016)
Alexandros K Pavlou et al.
Biosensors & bioelectronics, 17(10), 893-899 (2002-09-24)
The use of volatile production patterns produced by bacterial contaminants in urine samples were examined using electronic nose technology. In two experiments 25 and 45 samples from patients were analysed for specific bacterial contaminants using agar culture techniques and the
The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin
Harris G and Schaefer KL
Biochemical and Biophysical Research Communications, 388(2), 345-349 (2009)
Changsung Kim et al.
Nature, 494(7435), 105-110 (2013-01-29)
Cellular reprogramming of somatic cells to patient-specific induced pluripotent stem cells (iPSCs) enables in vitro modelling of human genetic disorders for pathogenic investigations and therapeutic screens. However, using iPSC-derived cardiomyocytes (iPSC-CMs) to model an adult-onset heart disease remains challenging owing
E M Schuman et al.
Proceedings of the National Academy of Sciences of the United States of America, 91(25), 11958-11962 (1994-12-06)
Recent studies of long-term potentiation (LTP) in the CA1 region of the hippocampus have demonstrated that nitric oxide (NO) may be involved in some forms of LTP and have suggested that postsynaptically generated NO is a candidate to act as
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service